Gilead, Teva Want 17 HIV Drug Antitrust Appeals Consolidated
By Matthew Perlman · May 16, 2024, 5:56 PM EDT
Gilead Sciences Inc. and Teva Pharmaceuticals are asking the Ninth Circuit to consolidate 17 appeals contesting their win in a case alleging they delayed generic versions of HIV medications, saying the...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login